The GM/CA @ APS project was established by the National Institute of General Medical Sciences (NIGMS) and the National Cancer Institute (NCI) of the National Institutes of Health (NIH) to develop and operate a national user facility for structure determination of biological macromolecules by X-ray crystallography. Our mission is to support challenging biomedical problems by providing a resource with state-of-the-art synchrotron technology.
GM/CA provides beam time on a peer-reviewed basis to the biological research community for investigations requiring advanced synchrotron capabilities. The scientific and technical goals of the GM/CA @ APS emphasize streamlined, efficient throughput for a variety of sample types, sizes and qualities, representing the cutting edge of structural biology research. The GM/CA @ APS facility offers X-ray beams of exceptional stability and tunability, equipment to reliably manipulate samples in the X-ray beam and record diffraction data, a powerful biologist-friendly user interface, and a pipeline for data processing with modern software.